Paraparetic Guillain-Barré syndrome: Nondemyelinating reversible conduction failure restricted to the lower limbs

Muscle and Nerve

Volumn 55, Issue 2, 2017, Pages 281-285

  Kimachi, Takeshi ^a   Yuki, Nobuhiro ^b   Kokubun, Norito ^c   Yamaguchi, Shuhei ^a   Wakerley, Benjamin R ^d,e  

^a The University of Shimane   (Japan)

^b Mishima Hospital   (Japan)

^c DOKKYO MEDICAL UNIVERSITY   (Japan)

^d GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

anti ganglioside antibodies; Guillain Barr syndrome; paraparesis; paraparetic Guillain Barr syndrome

Indexed keywords

GADOLINIUM; GANGLIOSIDE GM1 ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PROTEIN;

AGED; ARTICLE; CASE REPORT; CAUDA EQUINA; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CONTRAST ENHANCEMENT; DISEASE COURSE; FEMALE; FOLLOW UP; GUILLAIN BARRE SYNDROME; HUMAN; HYPOREFLEXIA; LEUKOCYTE COUNT; LIMB WEAKNESS; LUMBAR SPINE; MEDICAL HISTORY; MYOTATIC REFLEX; NERVE CONDUCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PARAPARETIC GUILLAIN BARRE SYNDROME; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SPINAL ROOT; SPINE RADIOGRAPHY; UPPER RESPIRATORY TRACT INFECTION; ELECTROMYOGRAPHY; HEMISPHERIC DOMINANCE; LOWER LIMB; MOTOR EVOKED POTENTIAL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE;

AGED; ELECTROMYOGRAPHY; EVOKED POTENTIALS, MOTOR; FEMALE; FUNCTIONAL LATERALITY; GUILLAIN-BARRE SYNDROME; HUMANS; LOWER EXTREMITY; MUSCLE, SKELETAL; NEURAL CONDUCTION;

EID: 85006135665     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.25242     Document Type: Article

References (23)

1. Yuki N, Hartung HP. Guillain-Barré syndrome. N Engl J Med 2012;366:2294–2304.
2. Ropper AH. Unusual clinical variants and signs in Guillain-Barré syndrome. Arch Neurol 1986;43:1150–1152.
3. Ropper AH, Wijdicks EFM, Truax BT. Guillain-Barré syndrome. Philadelphia: FA Davis Company; 1991.
4. Ropper AH. Further regional variants of acute immune polyneuropathy: bifacial weakness or sixth nerve paresis with paresthesias, lumbar polyradiculopathy, and ataxia with pharyngeal-cervical-brachial weakness. Arch Neurol 1994;51:671–675.
5. Beghi E, Bogliun G, Italian GBS Study Group. The Guillain-Barrè syndrome (GBS): implementation of a register of the disease on a nationwide basis. Ital J Neurol Sci 1996;17:355–361.
6. Carpo M, Pedotti R, Allaria S, Lolli F, Matà S, Cavaletti G, et al. Clinical presentation and outcome of Guillain-Barré and related syndromes in relation to anti-ganglioside antibodies. J Neurol Sci 1999;168:78–84.
7. Nagashima T, Kokubun N, Shahrizaila N, Funakoshi K, Hirata K, Yuki N. Paraparetic Guillain-Barré syndrome: extending the axonal spectrum. Neurol Clin Neurosci 2013;1:224–226.
8. Van den Berg B, Fokke C, Drenthen J, van Doorn PA, Jacobs BC. Paraparetic Guillain-Barré syndrome. Neurology 2014;82:1984–1989.
9. Wakerley BR, Yuki N. Mimics and chameleons in Guillain-Barré and Miller Fisher syndromes. Pract Neurol 2015;15:90–99.
10. Wakerley BR, Uncini A, Yuki N, GBS Classification Group. Guillain-Barré and Miller Fisher syndromes: new diagnostic classification. Nat Rev Neurol 2014;10:537–544.
11. Dyck PJ, Norell JE, Dyck PJ. Non-diabetic lumbosacral radiculoplexus neuropathy: natural history, outcome and comparison with the diabetic variety. Brain 2001;124:1197–1207.
12. Uncini A, Kuwabara S. Electrodiagnostic criteria for Guillain-Barrè syndrome: a critical revision and the need for an update. Clin Neurophysiol 2012;123:1487–1495.
13. Uncini A. 99 years of Guillain-Barré syndrome: pathophysiological insights from neurophysiology. Pract Neurol 2015;15:88–89.
14. Uncini A, Zappasodi F, Notturno F. Electrodiagnosis of GBS subtypes by a single study: not yet the squaring of the circle. J Neurol Neurosurg Psychiatry 2015;86:5–8.
15. Kokubun N, Shahrizaila N, Hirata K, Yuki N. Reversible conduction failure is distinct from neurophysiological patterns of recovery in mild demyelinating Guillain-Barré syndrome. J Neurol Sci 2013;15;326:111–114.
16. Hausmanowa-Petrusewicz I, Emeryk B, Rowińska-Marcińska K, Jedrzejowska H. Nerve conduction in the Guillain-Barré-Strohl syndrome. J Neurol 1979;220:169–184.
17. Kuwabara S, Ogawara K, Misawa S, Mizobuchi K, Sung JY, Kitano Y, et al. Sensory nerve conduction in demyelinating and axonal Guillain-Barré syndromes. Eur Neurol 2004;51:196–198.
18. Kuwabara S, Yuki N. Axonal Guillain-Barré syndrome: concepts and controversies. Lancet Neurol 2013;12:1180–1188.
19. Saida T, Saida K, Lisak RP, Brown MJ, Silberberg DH, Asbury AK. In vivo demyelinating activity of sera from patients with Guillain-Barré syndrome. Ann Neurol 1982;11:69–75.
20. Kokubun N, Nishibayashi M, Uncini A, Odaka M, Hirata K, Yuki N. Conduction block in acute motor axonal neuropathy. Brain 2010;133:2897–2908.
21. Uncini A, Susuki K, Yuki N. Nodo-paranodopathy: beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies. Clin Neurophysiol 2013;124:1928–1934.
22. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 1993;43:1911–1917.
23. Liu JX, Willison HJ, Pedrosa-Domellöf F. Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles. Invest Ophthalmol Vis Sci 2009;50:3226–3232.